Clinical Efficacy and Safety of Autologous Cultured Keratinocyte Cell on Severe Burn Wood

NCT00978705 · Status: UNKNOWN · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 19

Last updated 2009-09-17

No results posted yet for this study

Summary

The efficacy and safety of Autologous cultured keratinocyte cell on severe burn wound.

Conditions

  • Burn Wound

Interventions

DRUG

Autologous cultured keratinocyte cell

3x10\^7 cell/ vial

Sponsors & Collaborators

  • Biosolution Co., Ltd.

    lead INDUSTRY

Principal Investigators

  • Wook Chun, MD · Hangang Sacred Heart Hospital

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
1 Year
Max Age
70 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2007-11-30
Primary Completion
2008-05-31
Completion
2010-01-31

Countries

  • South Korea

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00978705 on ClinicalTrials.gov